A detailed history of Brown Advisory Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 820,510 shares of ABBV stock, worth $148 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
820,510
Previous 845,124 2.91%
Holding current value
$148 Million
Previous $145 Million 11.78%
% of portfolio
0.21%
Previous 0.19%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $4.03 Million - $4.91 Million
-24,614 Reduced 2.91%
820,510 $162 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $4.38 Million - $5.11 Million
28,278 Added 3.46%
845,124 $145 Million
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $3.12 Million - $3.56 Million
-19,530 Reduced 2.34%
816,846 $149 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $319,644 - $359,995
2,323 Added 0.28%
836,376 $130 Million
Q3 2023

Oct 24, 2023

SELL
$133.59 - $154.65 $1.48 Million - $1.71 Million
-11,073 Reduced 1.31%
834,053 $124 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $2 Million - $2.48 Million
-15,057 Reduced 1.75%
845,126 $114 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $652,480 - $751,428
4,512 Added 0.53%
860,183 $137 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $704,274 - $844,610
-5,092 Reduced 0.59%
855,671 $138 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2.75 Million - $3.16 Million
20,511 Added 2.44%
860,763 $116 Million
Q2 2022

Nov 14, 2022

BUY
$137.62 - $174.96 $973,936 - $1.24 Million
7,077 Added 0.85%
840,252 $129 Million
Q2 2022

Sep 13, 2022

SELL
$137.62 - $174.96 $720,440 - $915,915
-5,235 Reduced 0.6%
864,708 $132 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $1.7 Million - $2.16 Million
12,330 Added 1.44%
869,943 $128 Million
Q1 2022

Nov 14, 2022

SELL
$131.98 - $163.75 $4.16 Million - $5.16 Million
-31,533 Reduced 3.65%
833,175 $135 Million
Q1 2022

Sep 13, 2022

BUY
$131.98 - $163.75 $62,030 - $76,962
470 Added 0.05%
857,613 $139 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $1.43 Million - $1.78 Million
10,846 Added 1.28%
857,143 $130 Million
Q4 2021

Jan 27, 2022

BUY
$107.43 - $135.93 $1.23 Million - $1.55 Million
11,427 Added 1.37%
846,297 $115 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $5.5 Million - $6.24 Million
51,695 Added 6.6%
834,870 $90.1 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $886,289 - $987,377
8,424 Added 1.09%
783,175 $88.2 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $647,763 - $713,109
-6,332 Reduced 0.81%
774,751 $83.8 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $1.08 Million - $1.45 Million
13,366 Added 1.74%
781,083 $83.7 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $10.9 Million - $12.8 Million
126,935 Added 19.81%
767,717 $67.2 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $1.03 Million - $1.37 Million
14,001 Added 2.23%
640,782 $62.9 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $2.12 Million - $3.21 Million
32,864 Added 5.53%
626,781 $47.8 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $745,319 - $932,553
10,333 Added 1.77%
593,917 $52.6 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $358,734 - $431,301
5,696 Added 0.99%
583,584 $44.2 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $1.98 Million - $2.53 Million
-30,164 Reduced 4.96%
577,888 $42 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $2.59 Million - $3.05 Million
-33,544 Reduced 5.23%
608,052 $49 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $2.12 Million - $2.62 Million
-27,274 Reduced 4.08%
641,596 $59.1 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $499,140 - $554,887
-5,614 Reduced 0.83%
668,870 $63.3 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $783,150 - $926,644
-8,723 Reduced 1.28%
674,484 $62.5 Million
Q1 2018

Jun 28, 2018

BUY
$92.01 - $123.21 $9.25 Million - $12.4 Million
100,498 Added 17.25%
683,207 $64.7 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $19.5 Million - $26.2 Million
-212,260 Reduced 26.7%
582,709 $55.2 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $2.22 Million - $2.44 Million
-24,810 Reduced 3.03%
794,969 $76.9 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $466,109 - $595,365
-6,673 Reduced 0.81%
819,779 $72.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
826,452
826,452 $59.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.